Business
ATH starts 2nd Phase 2 Study in Rare Parkinsonian Disorder
ATH starts 2nd Phase 2 Study in Rare Parkinsonian Disorder
About this update from Alterity Therapeutics Ltd.
[{"type":"text","content":"Alterity Therapeutics Ltd has released a press release. View Attachment","length":253,"tagName":"div"}]